Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)
Key Information
Due Date: May 7, 2026
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant, Government
Match Required: No
Status: Posted
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
The Exploratory Clinical Neuroscience Research on Substance Use Disorders grant is a funding opportunity intended to support clinical research that concentrates on understanding the neurobiological mechanisms that underlie Substance Use Disorders (SUD). This research includes the study of fundamental brain functions relevant to substance usage. The funding is provided under the R61/R33 Phased Innovation Award activity code. This code represents a specific type of funding designed to support projects which are exploratory and developmental in nature. Importantly, this funding opportunity is primarily aimed at projects that demand budgets exceeding those allowed for the R21 mechanism used in Neuroscience Research on Drug Abuse. The R21 mechanism is another funding strategy, but unlike this grant, it is optional for conducting clinical trials.
Show More
Key Dates
Open Date: April 10, 2023
Application Due Date: May 7, 2026
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses